<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2173">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05132868</url>
  </required_header>
  <id_info>
    <org_study_id>61374</org_study_id>
    <secondary_id>VAR0214</secondary_id>
    <nct_id>NCT05132868</nct_id>
  </id_info>
  <brief_title>Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counseling</brief_title>
  <official_title>Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counseling</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to understand the impact of an educational video or&#xD;
      pamphlet on the patient experience in a hereditary cancer genetic counseling program. In&#xD;
      order to make this assessment, it is necessary to perform qualitative and quantitative&#xD;
      research among patients in a hereditary cancer genetic counseling clinic.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 25, 2021</start_date>
  <completion_date type="Anticipated">April 2024</completion_date>
  <primary_completion_date type="Anticipated">April 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient impact with educational information prior to genetic counseling</measure>
    <time_frame>36 months</time_frame>
    <description>Impact will be defined as the number of questions asked by patient during the counseling.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient impact without any educational information prior to genetic counseling</measure>
    <time_frame>36 months</time_frame>
    <description>Impact will be defined as the number of questions asked by patient during the counseling.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Quality</condition>
  <arm_group>
    <arm_group_label>pre-educated with educational video</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive a message to view educational videos prior to their genetic counseling appointment if they are assigned to a pre-educated arm. The video will be shared with patients via MyHealth in the &quot;education&quot; tab in advance of the genetic counseling session</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pre-educated with pamphlet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive a message to view a pamphlet prior to their genetic counseling appointment if they are assigned to a pre-educated arm. The pamphlet will be sent to patients who cannot access the video via regular mail in advance of the genetic counseling session</description>
  </arm_group>
  <arm_group>
    <arm_group_label>educated during the session</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants will receive traditional genetic counseling. . After the genetic counseling session, they will fill out a validated survey called the Multi-dimensional Measure of Informed Choice (MMIC) that assesses attitudes, knowledge, and uptake of genetic testing</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Educational video and pamphlet</intervention_name>
    <description>The primary intervention in this study is watching the video or reading the pamphlet in advance of the genetic counseling session, which overview the same information that we currently provide in-person/via telehealth during the genetic counseling session.</description>
    <arm_group_label>pre-educated with educational video</arm_group_label>
    <arm_group_label>pre-educated with pamphlet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Traditional genetic counseling</intervention_name>
    <description>Patients will receive traditional genetic counseling</description>
    <arm_group_label>educated during the session</arm_group_label>
    <arm_group_label>pre-educated with educational video</arm_group_label>
    <arm_group_label>pre-educated with pamphlet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Inclusion criteria for: Limited English Proficiency (LEP), primarily Spanish speaking&#xD;
        cohort&#xD;
&#xD;
          -  Preferred language for receiving medical information is Spanish&#xD;
&#xD;
          -  Has a personal or family history of cancer&#xD;
&#xD;
          -  If assigned to the arm where they need to be pre-educated with a video or pamphlet,&#xD;
             attests that they viewed the video or pamphlet&#xD;
&#xD;
        Inclusion criteria for: Individuals with a personal or family history of breast cancer&#xD;
        cohort&#xD;
&#xD;
          -  Personal or family history of breast cancer&#xD;
&#xD;
          -  English is preferred language&#xD;
&#xD;
          -  If assigned to the arm where they need to be pre-educated with a video or pamphlet,&#xD;
             attests that they viewed the video or pamphlet&#xD;
&#xD;
        Inclusion criteria for: Individuals with a personal or family history of prostate cancer&#xD;
        cohort&#xD;
&#xD;
          -  Personal or family history of prostate cancer&#xD;
&#xD;
          -  English is preferred language&#xD;
&#xD;
          -  If assigned to the arm where they need to be pre-educated with a video or pamphlet,&#xD;
             attests that they viewed the video or pamphlet&#xD;
&#xD;
        Inclusion criteria for: Individuals with a personal or family history of any type of cancer&#xD;
        referred for germline testing based on a genetic variant identified during tumor genomic&#xD;
        analysis for the patient or affected family member cohort.&#xD;
&#xD;
          -  Personal or family history of any type of cancer&#xD;
&#xD;
          -  Referred based on a variant identified during tumor genomic analysis&#xD;
&#xD;
          -  English is preferred language&#xD;
&#xD;
          -  If assigned to the arm where they need to be pre-educated with a video or pamphlet,&#xD;
             attests that they viewed the video or pamphlet&#xD;
&#xD;
        Inclusion criteria for: Individuals with a personal or family history of gastrointestinal&#xD;
        or gynecologic cancer, referred because they or their affected relative screened positive&#xD;
        for Lynch Syndrome based on either an immunohistochemistry test or evidence of mismatch&#xD;
        repair deficiency in their tumor cohort.&#xD;
&#xD;
          -  Personal or family history of gastrointestinal or gynecologic cancer&#xD;
&#xD;
          -  Screened positive for Lynch Syndrome based on IHC or MMR testing&#xD;
&#xD;
          -  English is preferred language&#xD;
&#xD;
          -  If assigned to the arm where they need to be pre-educated with a video or pamphlet,&#xD;
             attests that they viewed the video or pamphlet&#xD;
&#xD;
        Inclusion criteria for: Individuals with a personal or family history of ovarian and/or&#xD;
        pancreatic cancer cohort&#xD;
&#xD;
          -  Personal or family history of ovarian, and/or pancreatic cancer&#xD;
&#xD;
          -  English is preferred language&#xD;
&#xD;
          -  If assigned to the arm where they need to be pre-educated with a video or pamphlet,&#xD;
             attests that they viewed the video or pamphlet&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Individuals who are minors&#xD;
&#xD;
          -  Individuals who are decisionally impaired&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James Ford</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Misha Rashkin</last_name>
    <phone>650-724-5223</phone>
    <email>mrashkin@stanfordhealthcare.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Meredith Mills</last_name>
    <phone>650-724-5223</phone>
    <email>bluett@stanford.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Misha Rashkin</last_name>
      <email>mrashkin@stanfordhealthcare.org</email>
    </contact>
    <investigator>
      <last_name>Misha Rashkin</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karlena Otero</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Courtney Teeter</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 25, 2021</study_first_submitted>
  <study_first_submitted_qc>November 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 24, 2021</study_first_posted>
  <last_update_submitted>November 12, 2021</last_update_submitted>
  <last_update_submitted_qc>November 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cancer genetic counseling</keyword>
  <keyword>educational video</keyword>
  <keyword>pamphlet</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

